Correlation Between Viridian Therapeutics and Bytes Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Bytes Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Bytes Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Bytes Technology, you can compare the effects of market volatilities on Viridian Therapeutics and Bytes Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Bytes Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Bytes Technology.

Diversification Opportunities for Viridian Therapeutics and Bytes Technology

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Viridian and Bytes is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Bytes Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bytes Technology and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Bytes Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bytes Technology has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Bytes Technology go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Bytes Technology

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 2.31 times more return on investment than Bytes Technology. However, Viridian Therapeutics is 2.31 times more volatile than Bytes Technology. It trades about 0.14 of its potential returns per unit of risk. Bytes Technology is currently generating about -0.01 per unit of risk. If you would invest  1,486  in Viridian Therapeutics on August 31, 2024 and sell it today you would earn a total of  696.00  from holding Viridian Therapeutics or generate 46.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Bytes Technology

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bytes Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bytes Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bytes Technology is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Viridian Therapeutics and Bytes Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Bytes Technology

The main advantage of trading using opposite Viridian Therapeutics and Bytes Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Bytes Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bytes Technology will offset losses from the drop in Bytes Technology's long position.
The idea behind Viridian Therapeutics and Bytes Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals